Verrica Pharmaceuticals Ownership | Who Owns Verrica Pharmaceuticals?
Verrica Pharmaceuticals Ownership Summary
Verrica Pharmaceuticals is owned by 40.11% institutional investors, 32.18% insiders, and 27.71% retail investors. Perceptive advisors is the largest institutional shareholder, holding 15.27% of VRCA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.79% of its assets in Verrica Pharmaceuticals shares.
VRCA Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Verrica Pharmaceuticals | 40.11% | 32.18% | 27.71% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Perceptive advisors | 7.10M | 15.27% | $51.75M |
Vanguard group | 1.27M | 2.73% | $9.25M |
Blackrock | 1.13M | 2.43% | $8.23M |
Fmr | 1.11M | 2.39% | $8.08M |
Geode capital management | 463.36K | 1.00% | $3.38M |
State street | 451.78K | 0.97% | $3.29M |
Propel bio management | 424.94K | 0.91% | $3.10M |
Invesco | 423.52K | 0.91% | $3.09M |
Simplify asset management | 280.00K | 0.60% | $2.04M |
Northern trust | 190.68K | 0.41% | $1.39M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Propel bio management | 424.94K | 2.01% | $3.10M |
Perceptive advisors | 7.10M | 1.23% | $51.75M |
Bml capital management | 180.00K | 0.94% | $1.31M |
Simplify asset management | 280.00K | 0.14% | $2.04M |
Steel peak wealth management | 122.84K | 0.04% | $895.48K |
Spc financial | 30.00K | 0.02% | $218.70K |
Key financial | 9.41K | 0.02% | $68.64K |
Miracle mile advisors | 84.00K | 0.01% | $612.36K |
Bridgeway capital management | 82.20K | 0.01% | $599.24K |
Kovitz investment group partners | 100.13K | 0.01% | $729.91K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Propel bio management | 424.94K | 2.01% | 424.94K |
Invesco | 423.52K | 0.00% | 423.52K |
Simplify asset management | 280.00K | 0.14% | 280.00K |
Kovitz investment group partners | 100.13K | 0.01% | 50.00K |
Renaissance | 45.52K | 0.00% | 45.52K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Avoro capital advisors | - | - | -4.00M |
Fmr | 1.11M | 0.00% | -400.50K |
Kornitzer capital management inc /ks | - | - | -74.25K |
Eam investors | - | - | -70.59K |
Morgan stanley | 84.94K | - | -49.28K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Propel bio management | 424.94K | 2.01% | 424.94K | $3.10M |
Invesco | 423.52K | 0.00% | 423.52K | $3.09M |
Simplify asset management | 280.00K | 0.14% | 280.00K | $2.04M |
Renaissance | 45.52K | 0.00% | 45.52K | $331.88K |
Alliancebernstein | 12.20K | - | 12.20K | $88.94K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -4.00 |
Farther finance advisors | -31.00 |
Quadrant capital group | -110.00 |
Parallel advisors | -176.00 |
Old point trust & financial services n a | -500.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 74 | 21.31% | 18,643,941 | 5.04% | 40 | 2.62% | 38 | 111.11% | 16 | -20.00% |
Mar 31, 2024 | 61 | -7.58% | 17,749,027 | -1.42% | 39 | 2.56% | 18 | -41.94% | 20 | 17.65% |
Dec 31, 2023 | 66 | -4.35% | 18,004,540 | 19.63% | 39 | 3.64% | 31 | 6.90% | 17 | -10.53% |
Sep 30, 2023 | 69 | 4.55% | 15,050,397 | 3.08% | 32 | 2.85% | 29 | -30.95% | 19 | 171.43% |
Jun 30, 2023 | 66 | 4.76% | 14,600,620 | 13.01% | 33 | 3.76% | 42 | 10.53% | 7 | -46.15% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 815.89K | 1.79% | - |
Fidelity Select Biotechnology | 629.87K | 1.48% | -478.20K |
iShares Russell 2000 ETF | 540.97K | 1.19% | -1.22K |
Invesco Dorsey Wright SmallCap Momt ETF | 409.00K | 0.96% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 289.25K | 0.68% | - |
State St Russell Sm/Mid Cp® Indx NL Cl C | 213.00K | 0.47% | - |
Fidelity Small Cap Index | 196.51K | 0.46% | -3.61K |
Simplify Propel Opportunities ETF | 200.00K | 0.44% | - |
iShares Russell 2000 Growth ETF | 197.33K | 0.43% | - |
DWS Small Cap Core S | 174.70K | 0.41% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 27, 2024 | Hayes Christopher G. | CHIEF LEGAL OFFICER | Sell | $23.44K |
Aug 26, 2024 | Hayes Christopher G. | CHIEF LEGAL OFFICER | Sell | $69.65K |
Aug 26, 2024 | Goldenberg Gary | Chief Medical Officer | Sell | $26.30K |
Aug 27, 2024 | Goldenberg Gary | Chief Medical Officer | Sell | $8.86K |
Aug 26, 2024 | Bonaccorso Joe | CHIEF COMMERCIAL OFFICER | Sell | $65.73K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | - |
2024 Q3 | - | 18 |
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q4 | 9 | 10 |
VRCA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools